Open AccessRandomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
Author(s) -
Mary O’Brien,
Mark A. Socinski,
Alexander Y. Popovich,
Igor Bondarenko,
Antoaneta Tomova,
Borys T. Bilynsky ̆ı,
Yevhen Hotko,
V.L. Ganul,
Ippolit Y. Kostinsky,
Amy J. Eisenfeld,
Larissa Sandalic,
Fred B. Oldham,
B. Bandstra,
Alan Sandler,
Jack W. Singer
Publication year - 2008
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/ygtf-rq83
Subject(s) - vinorelbine , gemcitabine , medicine , chemotherapy , paclitaxel , oncology , cisplatin